To Evaluate the Immunogenicity and Safety of Sequential Booster Immunization of Recombinant Novel Coronavirus Vaccine (CHO Cells) for SARS-CoV-2
Clinical trial NCT05895110 · COMPLETED
Trial details
- NCT number
- NCT05895110
- Sponsor
- Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-29
- Primary completion
- 2022-11-19
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.